GEODE CAPITAL MANAGEMENT, LLC - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 68 filers reported holding EVELO BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$109,987
+11157.6%
608,675
+0.2%
0.00%
Q4 2022$977
-99.9%
607,443
+3.6%
0.00%
Q3 2022$1,225,000
+67.6%
586,483
+69.1%
0.00%
Q2 2022$731,000
-60.5%
346,726
-36.5%
0.00%
Q1 2022$1,850,000
-41.8%
545,923
+4.3%
0.00%
Q4 2021$3,178,000
-13.3%
523,575
+0.5%
0.00%
Q3 2021$3,665,000
-43.5%
520,717
+10.3%
0.00%
-100.0%
Q2 2021$6,487,000
+57.2%
472,138
+22.4%
0.00%0.0%
Q1 2021$4,127,000
+4.5%
385,734
+18.0%
0.00%0.0%
Q4 2020$3,951,000
+261.8%
326,820
+57.7%
0.00%
Q3 2020$1,092,000
+40.2%
207,259
+30.3%
0.00%
Q2 2020$779,000
+46.7%
159,078
+12.5%
0.00%
Q1 2020$531,000
-48.3%
141,430
-44.2%
0.00%
Q4 2019$1,028,000
+41.6%
253,436
+112.7%
0.00%
Q3 2019$726,000
-32.0%
119,177
+0.3%
0.00%
Q2 2019$1,067,000
+30.3%
118,870
+16.0%
0.00%
Q1 2019$819,000
-65.1%
102,462
-43.2%
0.00%
Q4 2018$2,346,000
+273.6%
180,394
+249.6%
0.00%
Q3 2018$628,000
+7.0%
51,601
+3.7%
0.00%
Q2 2018$587,00049,7770.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders